Biosplice Therapeutics adds Dave Johnson to its Board as Independent Director

– USA, CA –  Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases, today announced the addition of Dave Johnson, most recently Founder and CEO of VelosBio, to its Board as an independent director.…